{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T01:56:33Z","timestamp":1749606993147,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07616-w","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:02:12Z","timestamp":1720530132000},"page":"1331-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk of teratogenicity in continued pregnancy after gestational exposure to mifepristone and\/or misoprostol: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"310","author":[{"given":"Gao","family":"Jingran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-5104","authenticated-orcid":false,"given":"Yao","family":"Xiaoying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"7616_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/humrep\/deh005","volume":"19","author":"A Aronsson","year":"2004","unstructured":"Aronsson A, Bygdeman M, Gemzell-Danielsson K (2004) Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 19:81\u201384. https:\/\/doi.org\/10.1093\/humrep\/deh005","journal-title":"Hum Reprod"},{"key":"7616_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0010-7824(03)00171-9","volume":"68","author":"R Sitruk-Ware","year":"2003","unstructured":"Sitruk-Ware R, Spitz IM (2003) Pharmacological properties of mifepristone: toxicology and safety in animal and human studies. Contraception 68:409\u2013420. https:\/\/doi.org\/10.1016\/S0010-7824(03)00171-9","journal-title":"Contraception"},{"key":"7616_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12512","volume":"22","author":"Y Osuga","year":"2023","unstructured":"Osuga Y, Shirasu K, Tsushima R, Ishitani K (2023) Short-term efficacy and safety of early medical abortion in Japan: a multicenter prospective study. Reprod Med Biol 22:e12512. https:\/\/doi.org\/10.1002\/rmb2.12512","journal-title":"Reprod Med Biol"},{"key":"7616_CR4","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jogc.2020.04.006","volume":"42","author":"I Ferguson","year":"2020","unstructured":"Ferguson I, Scott H (2020) Systematic review of the effectiveness, safety, and acceptability of mifepristone and misoprostol for medical abortion in low- and middle-income countries. J Obstet Gynaecol Ca 42:1532-1542.e2. https:\/\/doi.org\/10.1016\/j.jogc.2020.04.006","journal-title":"J Obstet Gynaecol Ca"},{"key":"7616_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00019605-199301000-00011","volume":"2","author":"W Fonseca","year":"1993","unstructured":"Fonseca W, Alencar AJ, Pereira RM, Misago C (1993) Congenital malformation of the scalp and cranium after failed first trimester abortion attempt with misoprostol. Clin Dysmorphol 2:76\u201380. https:\/\/doi.org\/10.1097\/00019605-199301000-00011","journal-title":"Clin Dysmorphol"},{"key":"7616_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1345\/aph.1K550","volume":"42","author":"M-A Bos-Thompson","year":"2008","unstructured":"Bos-Thompson M-A, Hillaire-Buys D, Roux C et al (2008) M\u00f6bius syndrome in a neonate after mifepristone and misoprostol elective abortion failure. Ann Pharmacother 42:888\u2013892. https:\/\/doi.org\/10.1345\/aph.1K550","journal-title":"Ann Pharmacother"},{"key":"7616_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3109\/13625187.2010.512672","volume":"15","author":"AA Rouzi","year":"2010","unstructured":"Rouzi AA (2010) Abortion failure after illegal use of misoprostol\u2013a case report. Eur J Contracept Reprod Health Care 15:376\u2013378. https:\/\/doi.org\/10.3109\/13625187.2010.512672","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"7616_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"key":"7616_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1471-0528.2000.tb13272.x","volume":"107","author":"IM Orioli","year":"2000","unstructured":"Orioli IM, Castilla EE (2000) Epidemiological assessment of misoprostol teratogenicity. BJOG 107:519\u2013523. https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb13272.x","journal-title":"BJOG"},{"key":"7616_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0890-6238(98)00072-0","volume":"13","author":"L Sch\u00fcler","year":"1999","unstructured":"Sch\u00fcler L, Pastuszak A, Sanseverino TV et al (1999) Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study. Reprod Toxicol 13:147\u2013151. https:\/\/doi.org\/10.1016\/s0890-6238(98)00072-0","journal-title":"Reprod Toxicol"},{"key":"7616_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/1096-8628(20001211)95:4<302::AID-AJMG2>3.0.CO;2-B","volume":"95","author":"FR Vargas","year":"2000","unstructured":"Vargas FR, Schuler-Faccini L, Brunoni D et al (2000) Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 95:302\u2013306. https:\/\/doi.org\/10.1002\/1096-8628(20001211)95:4%3c302::AID-AJMG2%3e3.0.CO;2-B","journal-title":"Am J Med Genet"},{"key":"7616_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.reprotox.2012.11.009","volume":"36","author":"C Vauzelle","year":"2013","unstructured":"Vauzelle C, Beghin D, Cournot M-P, Elefant E (2013) Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study. Reprod Toxicol 36:98\u2013103. https:\/\/doi.org\/10.1016\/j.reprotox.2012.11.009","journal-title":"Reprod Toxicol"},{"key":"7616_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/1471-0528.12147","volume":"120","author":"N Bernard","year":"2013","unstructured":"Bernard N, Elefant E, Carlier P et al (2013) Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study. BJOG 120:568\u2013575. https:\/\/doi.org\/10.1111\/1471-0528.12147","journal-title":"BJOG"},{"key":"7616_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.contraception.2006.03.016","volume":"74","author":"R Sitruk-Ware","year":"2006","unstructured":"Sitruk-Ware R (2006) Mifepristone and misoprostol sequential regimen side effects, complications and safety. Contraception 74:48\u201355. https:\/\/doi.org\/10.1016\/j.contraception.2006.03.016","journal-title":"Contraception"},{"key":"7616_CR15","first-page":"782","volume":"9","author":"JL Li","year":"2016","unstructured":"Li JL, Zhao RF (2016) Effect of mifepristone on pregnance in 100 cases after the failure of emergency contraception. Chin J New Clin Med 9:782\u2013784","journal-title":"Chin J New Clin Med"},{"key":"7616_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5005\/jp-journals-10016-1310","volume":"14","author":"R Izhar","year":"2023","unstructured":"Izhar R, Husain S, Tahir MA et al (2023) Comparison of pregnancy outcomes between ongoing pregnancies after accidental misoprostol use and normal pregnancies: a case-control Study. Int J Infertil Fetal Med 14:31\u201337. https:\/\/doi.org\/10.5005\/jp-journals-10016-1310","journal-title":"Int J Infertil Fetal Med"},{"key":"7616_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJM199806253382604","volume":"338","author":"AL Pastuszak","year":"1998","unstructured":"Pastuszak AL, Sch\u00fcler L, Speck-Martins CE et al (1998) Use of Misoprostol during pregnancy and M\u00f6bius\u2019 syndrome in infants. New Engl J Med 338:1881\u20131885. https:\/\/doi.org\/10.1056\/NEJM199806253382604","journal-title":"New Engl J Med"},{"key":"7616_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1590\/s0100-72032010000100004","volume":"32","author":"ES Opaleye","year":"2010","unstructured":"Opaleye ES, Coelho HLL, Sch\u00fcler-Faccini L et al (2010) Evaluation of the teratogenic risks in gestations exposed to misoprostol. Rev Bras Ginecol Obstet 32:19\u201335. https:\/\/doi.org\/10.1590\/s0100-72032010000100004","journal-title":"Rev Bras Ginecol Obstet"},{"key":"7616_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/1099-1557(200009\/10)9:5<401::AID-PDS527>3.0.CO;2-1","volume":"9","author":"R Brasil","year":"2000","unstructured":"Brasil R, Coelho HL, D\u2019Avanzo B, La Vecchia C (2000) Misoprostol and congenital anomalies. Pharmacoepidem Dr S 9:401\u2013403. https:\/\/doi.org\/10.1002\/1099-1557(200009\/10)9:5%3c401::AID-PDS527%3e3.0.CO;2-1","journal-title":"Pharmacoepidem Dr S"},{"key":"7616_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1590\/S0325-00752011000300007","volume":"109","author":"P Barbero","year":"2011","unstructured":"Barbero P, Liascovich R, Valdez R, Moresco A (2011) Misoprostol teratogenicity: a prospective study in Argentina. Arch Argent Pediatr 109:226\u2013231. https:\/\/doi.org\/10.1590\/S0325-00752011000300007","journal-title":"Arch Argent Pediatr"},{"key":"7616_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1590\/s0102-311x2008000600025","volume":"24","author":"T Dal Pizzol","year":"2008","unstructured":"Dal Pizzol T, da S, Sanseverino MTV, Mengue SS, (2008) Exposure to misoprostol and hormones during pregnancy and risk of congenital anomalies. Cad Saude Publica 24:1447\u20131453. https:\/\/doi.org\/10.1590\/s0102-311x2008000600025","journal-title":"Cad Saude Publica"},{"key":"7616_CR22","volume-title":"Abortion care guideline","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022) Abortion care guideline. World Health Organization, Geneva"},{"key":"7616_CR23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.reprotox.2006.03.015","volume":"22","author":"T Dal Pizzol","year":"2006","unstructured":"Dal Pizzol T, da S, Knop FP, Mengue SS, (2006) Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis. Reprod Toxicol 22:666\u2013671. https:\/\/doi.org\/10.1016\/j.reprotox.2006.03.015","journal-title":"Reprod Toxicol"},{"key":"7616_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/lio2.377","volume":"5","author":"NO Ruge-Pe\u00f1a","year":"2020","unstructured":"Ruge-Pe\u00f1a NO, Valencia C, Cabrera D et al (2020) Moebius syndrome: craniofacial clinical manifestations and their association with prenatal exposure to misoprostol. Laryngoscope Invest 5:727\u2013733. https:\/\/doi.org\/10.1002\/lio2.377","journal-title":"Laryngoscope Invest"},{"key":"7616_CR25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S0140-6736(97)12363-7","volume":"351","author":"CH Gonzalez","year":"1998","unstructured":"Gonzalez CH, Marques-Dias MJ, Kim CA et al (1998) Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 351:1624\u20131627. https:\/\/doi.org\/10.1016\/S0140-6736(97)12363-7","journal-title":"Lancet"},{"key":"7616_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/fcp.12065","volume":"28","author":"M Auffret","year":"2014","unstructured":"Auffret M, B\u00e9n\u00e9 J, Dekemp J et al (2014) Teratogenic risk of misoprostol during first-trimester exposure: a cohort study. Fund Clin Pharmacol 28:67\u201368. https:\/\/doi.org\/10.1111\/fcp.12065","journal-title":"Fund Clin Pharmacol"},{"key":"7616_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2147\/IJWH.S61543","volume":"6","author":"HH Le","year":"2014","unstructured":"Le HH, Connolly MP, Bahamondes L et al (2014) The burden of unintended pregnancies in Brazil: a social and public health system cost analysis. Int J Womens Health 6:663\u2013670. https:\/\/doi.org\/10.2147\/IJWH.S61543","journal-title":"Int J Womens Health"},{"key":"7616_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00019605-199901000-00010","volume":"8","author":"DR Genest","year":"1999","unstructured":"Genest DR, Di Salvo D, Rosenblatt MJ, Holmes LB (1999) Terminal transverse limb defects with tethering and omphalocele in a 17 week fetus following first trimester misoprostol exposure. Clin Dysmorphol 8:53\u201358. https:\/\/doi.org\/10.1097\/00019605-199901000-00010","journal-title":"Clin Dysmorphol"},{"key":"7616_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1590\/s0004-282x1999000100017","volume":"57","author":"ML Nunes","year":"1999","unstructured":"Nunes ML, Friedrich MA, Loch LF (1999) Association of misoprostol, Moebius syndrome and congenital central alveolar hypoventilation. Arq Neuro-Psiquiat 57:88\u201391. https:\/\/doi.org\/10.1590\/s0004-282x1999000100017","journal-title":"Arq Neuro-Psiquiat"},{"key":"7616_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2023.108488","volume":"122","author":"B Danielsson","year":"2023","unstructured":"Danielsson B, Vargesson N, Danielsson C (2023) Teratogenicity and Reactive Oxygen Species after transient embryonic hypoxia: Experimental and clinical evidence with focus on drugs causing failed abortion in humans. Reprod Toxicol 122:108488. https:\/\/doi.org\/10.1016\/j.reprotox.2023.108488","journal-title":"Reprod Toxicol"},{"key":"7616_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0301-2115(01)00522-X","volume":"101","author":"NN Sarkar","year":"2002","unstructured":"Sarkar NN (2002) Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. Eur J Obstet Gyn R B 101:113\u2013120. https:\/\/doi.org\/10.1016\/S0301-2115(01)00522-X","journal-title":"Eur J Obstet Gyn R B"},{"key":"7616_CR32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.13748\/j.cnki.issn1007-7693.2017.11.023","volume":"34","author":"W Jiang","year":"2017","unstructured":"Jiang W, Chen Y (2017) Safety of Continuation of Pregnancy After First-trimester Exposure to Mifepristone and Prostaglandin. Chin J Mod Appl Pharm 34:1601\u20131604. https:\/\/doi.org\/10.13748\/j.cnki.issn1007-7693.2017.11.023","journal-title":"Chin J Mod Appl Pharm"},{"key":"7616_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.13604\/j.cnki.46-1064\/r.2010.05.051","volume":"10","author":"W Tang","year":"2010","unstructured":"Tang W, Wang Z, Zhao Y (2010) Effect of mifepristone on expression of VEGF in human placental villous trophoblast. Chin Trop Med 10:584\u2013603. https:\/\/doi.org\/10.13604\/j.cnki.46-1064\/r.2010.05.051","journal-title":"Chin Trop Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07616-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07616-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07616-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T02:06:14Z","timestamp":1725242774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07616-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["7616"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07616-w","relation":{},"ISSN":["1432-0711"],"issn-type":[{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors gave consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}